Discontinued Operations (Tables)

9 Months Ended

Sep. 30, 2022

PrescribeWellness business | Discontinued Operations, Disposed of by Sale

Discontinued Operations

Schedules of discontinued operations

The following table summarizes the net assets sold as finally reported on the sale date of August 1, 2022 and as of December 31, 2021, classified as discontinued operations on the consolidated balance sheets as of December 31, 2021:

	August 1,		December 31,
	2022		2021
Accounts receivable, net	$	5,020		8,002
Prepaid expenses and other assets		1,751		1,038
Property and equipment, net		371		—
Operating lease right-of-use assets		1,252		—
Software development costs, net		14,536		—
Goodwill		35,314		—
Intangible assets, net		81,504		—
Impairment of carrying value		(8,500)		—
Total current assets of discontinued operations	$	131,248	$	9,040
Property and equipment, net	$	—	$	412
Operating lease right-of-use assets		—		1,434
Software development costs, net		—		11,474
Goodwill		—		47,459
Intangible assets, net		—		84,617
Other assets		—		64
Total noncurrent assets of discontinued operations	$	—	$	145,460
Operating lease liabilities	$	1,086	$	620
Accounts payable		491		913
Accrued expenses and other liabilities		2,754		3,529
Total current liabilities of discontinued operations	$	4,331	$	5,062
Noncurrent operating lease liabilities	$	—	$	830
Other long-term liabilities		—		135
Total noncurrent liabilities of discontinued operations	$	—	$	965

The following table summarizes the results of operations of the PrescribeWellness Business, which are included in loss from discontinued operations, net of tax in the consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
Revenue	$	2,537	$	10,533	$	19,306	$	27,629
Cost of revenue, exclusive of depreciation and amortization		1,229		3,426		7,747		9,883
Operating expenses		2,336		8,373		14,930		24,427
Impairment charges		—		—		20,645		—
Loss on disposal of business		2,879		—		2,879		—
Loss from discontinued operations before income taxes		(3,907)		(1,266)		(26,895)		(6,681)
Income tax (benefit) expense		(11)		12		(299)		66
Net loss from discontinued operations, net of tax	$	(3,896)	$	(1,278)	$	(26,596)	$	(6,747)

The following table summarizes the significant operating non-cash items and investing activities of PrescribeWellness Business:

	Nine Months Ended
	September 30,
	2022		2021
Depreciation and amortization	$	4,551	$	12,059
Impairment charges		20,645		—
Stock-based compensation		1,697		2,352
Loss on disposal of business		2,879		—
Purchases of property and equipment		(22)		(305)
Software development costs		(4,443)		(9,783)

DoseMe and SinfonaRx businesses | Discontinued Operations, Held-for-sale

Discontinued Operations

Schedules of discontinued operations

The following table summarizes the results of operations of the DoseMe and SinfoníaRx businesses, which are included in loss from discontinued operations, net of tax in the consolidated statements of operations for the three and nine months ended September 30, 2022 and 2021:

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2022		2021		2022		2021
Revenue	$	6,407	$	8,143	$	23,094	$	26,961
Cost of revenue, exclusive of depreciation and amortization		7,055		6,521		20,479		19,755
Operating expenses		3,879		5,659		13,639		18,827
Impairment charges		5,845		—		21,648		—
Loss from discontinued operations before income taxes		(10,372)		(4,037)		(32,672)		(11,621)
Income tax (benefit) expense		(83)		40		(363)		116
Net loss from discontinued operations, net of tax	$	(10,289)	$	(4,077)	$	(32,309)	$	(11,737)

The following table summarizes the DoseMe and SinfoníaRx businesses’ current and noncurrent assets and liabilities classified as discontinued operations on the consolidated balance sheets as of September 30, 2022 and December 31, 2021:

	September 30,		December 31,
	2022		2021
Cash	$	69	$	273
Accounts receivable, net		4,964		4,644
Prepaid expenses and other assets		796		554
Property and equipment, net		1,349		—
Operating lease right-of-use assets		3,732		—
Software development costs, net		6,910		—
Goodwill		1,927		—
Intangible assets, net		22,635		—
Impairment of carrying value		(15,521)		—
Total current assets of discontinued operations	$	26,861	$	5,471
Property and equipment, net	$	—	$	1,485
Operating lease right-of-use assets		—		3,296
Software development costs, net		—		4,466
Goodwill		—		8,053
Intangible assets, net		—		24,675
Other assets		—		123
Total noncurrent assets of discontinued operations	$	—	$	42,098
Operating lease liabilities	$	3,458	$	793
Accounts payable		3,077		3,395
Accrued expenses and other liabilities		4,597		3,130
Total current liabilities of discontinued operations	$	11,132	$	7,318
Noncurrent operating lease liabilities		—	$	2,608
Other long-term liabilities		—		—
Total noncurrent liabilities of discontinued operations	$	—	$	2,608

The following table summarizes the DoseMe and SinfoníaRx businesses’ significant operating non-cash items and investing activities of discontinued operations:

	Nine Months Ended
	September 30,
	2022		2021
Depreciation and amortization	$	2,780	$	8,175
Impairment charges		21,648		—
Stock-based compensation		2,667		2,510
Purchases of property and equipment		(50)		(1,323)
Software development costs		(2,998)		(6,155)